Yingzhi Bi

Yingzhi Bi is a highly experienced medicinal chemist currently serving as Director and Senior Director at HotSpot Therapeutics, Inc., where responsibilities include leading chemistry efforts for oncology projects and managing outsourced FTEs. Prior experience includes roles at Arbutus Biopharma Corporation as Principal Scientist and Senior Principal Scientist, focusing on immunology and antiviral projects, and at Lexicon Pharmaceuticals as Associate Director, where leadership extended to neuroscience chemistry teams and multiple collaborative projects. Earlier in the career, Yingzhi Bi held positions at Bristol-Myers Squibb and Wyeth-Ayerst Research, contributing to drug discovery through design and synthesis of organic molecules, with significant achievements including the development of a compound that entered human clinical trials. Yingzhi Bi holds a PhD in Organic Chemistry from the University of Wisconsin-Milwaukee.